Health Spending Is Rising More Sharply Again
In this column for The Wall Street Journal's Think Tank, Drew Altman discusses why high health care prices are a problem for consumers but not a cause of renewed growth in health spending.
View the Latest: Prices
Filter
-
-
Visualizing Health Policy: Recent Trends in Prescription Drug Costs
Other PostThis Visualizing Health Policy infographic with JAMA spotlights national spending on prescription drugs and the public’s views on pharmaceutical prices.
-
Health of the Healthcare System: An Overview
FeatureThis slideshow accompanies the video, “Health of the Healthcare System,” a diagnostic look at the state of the U.S. healthcare system. It compares the United States to other countries in four key areas: health, quality of health care, cost of care, and accessibility.
-
How Costly Are Common Health Services in the United States?
FeatureA new chart collection examines what we know about the cost of common health services in the U.S. The analysis shows that costs for many common health services have risen more rapidly than inflation; for example, the average cost of hospital admission among large employer plans increased by about $10,000 (68%) between 2008 and 2018. Additionally, there are large geographic variations in the cost of the same health services across the U.S. A lower back…
-
Health Policy Resources for Covering the 2020 Elections
News ReleaseAs the 2020 Election Day approaches, many candidates continue to focus on health care issues, including on the public health and economic response to COVID-19, the future of the Affordable Care Act, health care costs and abortion. To help reporters understand and cover these issues, KFF offers independent, non-partisan policy analysis, polling and other research and has experts who can provide context, explain trade-offs and provide key data points on health care issues that may arise…
-
Why Higher Drug Costs Are Consumers’ Biggest Cost Worry
News ReleaseIn his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health care costs. All previous columns by Drew Altman are available online.
-
Web Event: Rx Drugs and the U.S. Health System – A Conversation About Drug Prices
Event Date:EventThe Kaiser Family Foundation will host a web conversation to discuss the drivers of recent and forecasted trends in prescription drug spending and examine how drug prices are set.
-
Privately Insured People with Depression and Anxiety Face High Out-of-Pocket Costs
Issue BriefThis analysis finds that privately insured adults who were treated for depression and/or anxiety in 2021 spent almost twice as much on annual out-of-pocket costs compared to enrollees who were not treated for a mental health diagnosis.
-
Health Spending Issues to Watch This Year
Issue BriefKFF and the Peterson Center on Healthcare examine market trends contributing to rising health costs and identify several potential federal and state policy issues to watch throughout 2025, including high-cost drugs, federal funding cuts, and workforce shortages.
-
Will President Trump’s Executive Order Lower Drug Prices?
Quick InsightsUltimately, assessing the impact of President Trump’s newest iteration of “Most Favored Nation” drug pricing depends on details that have yet to be fleshed out.